Exposure to Endocrine Disruptors and Occurrence of Hypospadias: Toxicological, Environmental and Hormonal Imbalance Study

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

This study aims to demonstrate the impact of Endocrine-Disrupting Chemicals (EDCs) on the risk of hypospadias incidence. It is a multicenter comparative case-control study, involving two groups. The first group consists of biological mothers who have given birth to children with hypospadias (Case Group), while the second group consists of biological mothers who have given birth to children without any malformations (Control Group). Through an integrative approach that combines a direct toxicological study of numerous pollutants present during pregnancy, and a comprehensive exposome assessment using validated tools, this study can significantly enhance our understanding and prevention of this malformation.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 1 month
Healthy Volunteers: t
View:

• \- The child has an isolated anterior or middle hypospadias, without any other complex variations of genital development (borderline penile size, unilateral or bilateral cryptorchidism, retractile testes), without malformation syndrome and without identified genetic etiology

• \- The child must not present any complex variations in genital development (hypospadias, borderline penis size, unilateral or bilateral cryptorchidism, retractile testes)

Locations
Other Locations
France
CRMR DEVGEN CHU Lapeyronnie
RECRUITING
Montpellier
Contact Information
Primary
Nicolas KALFA, Prof
n-kalfa@chu-montpellier.fr
0467338784
Time Frame
Start Date: 2024-10-03
Estimated Completion Date: 2027-10-03
Participants
Target number of participants: 200
Treatments
Case Group
Biological mother and son with hypospadias
Control Group
Biological mother and son without hypospadias
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Montpellier

This content was sourced from clinicaltrials.gov